Objective: To update trends in mortality by ethnic group from the New Zealand Census-Mortality Study (NZCMS), by additionally linking 2004-06 mortality records to the 2001 Census. To investigate possible bias from this extended linkage, especially for Pacific and Asian people who emigrate more frequently.
Methods: Anonymous and probabilistic record linkage of 2004-06 mortality records with the 2001 Census was undertaken. Age-standardised 1-74 year old mortality rates by sex and age group, and for all-cause and selected causes of death, were calculated using the direct method for first 30 months post 2001 Census (2001-03) and second 30 months (2003-06).
Results: Observed all-cause mortality rates continued to fall in 2003-06 compared to previous periods, but more so for Pacific (18.3% and 21.7% for males and females for 2003-06 compared to 2001-04, respectively) and Asian (22.2%, 16.7%), than for Maori (13.2%, 14.2%) and European/Other (13.0%, 10.4%). Observed rate ratios for Maori, compared to European/Other were 2.43 (95% CI 2.31-2.57) for males and 2.72 (2.56-2.89) for females, the same (males) and slightly less (7%, females) than in 2001-03. Declines in cardiovascular disease (CVD) and injury mortality were the main drivers of all-cause mortality rate reductions for all ethnic groups. Relative inequalities in CVD between Maori and European/Other remain high (three to four-fold relative risks), but reduced by 8% for both males and females from 2001-03 to 2003-06, which in turn means that absolute inequalities closed by as much as 20%.
Conclusion: We suspect that analyses comparing mortality rates over time within one of the closed NZCMS cohorts (e.g. 2001-03 compared to 2003-06) is prone to bias due to our inability to censor people when they migrate out of New Zealand. This limitation means mortality rates in the NZCMS are increasingly underestimated with time since census night, particularly for Pacific and Asian people. However, previously published NZCMS trends remain valid as the duration of follow-up (3 years) is short, and cohorts were not split by time since census. Nevertheless, it is safe to conclude that mortality rates continued to decline from 2001-03 to 2003-04 for all four ethnic groups. All-cause mortality inequalities for Maori compared to European/Other over this time were probably stable in relative terms and decreasing in absolute terms, but cardiovascular disease (CVD) inequalities probably decreased in both absolute and relative terms.
Download full-text PDF |
Source |
---|
Dig Dis Sci
January 2025
Department of Internal Medicine and Center for Recovery Medicine, Allegheny General Hospital, 1307 Federal St Suite B300, Pittsburgh, PA, 15212, USA.
Background: Alcohol use disorder and alcohol-associated liver disease is increasing in the US, with subsequent and expected increases in morbidity and mortality due to these conditions.
Aims: To determine the impact of an educational intervention regarding alcohol use disorder on gastroenterology fellows.
Methods: A before-after survey study was carried out.
Dig Dis Sci
January 2025
Ningxia Medical University, Xing Qing Block, Shengli Street No.1160, Yin Chuan City, 750004, Ningxia Province, People's Republic of China.
Background: Colon adenocarcinoma (COAD) is a leading cause of cancer-related mortality worldwide. Transient receptor potential vanilloid 4 (TRPV4), a calcium-permeable non-selective cation channel, has been implicated in various cancers, including COAD. This study investigates the role of TRPV4 in colon adenocarcinoma and elucidates its potential mechanism via the ferroptosis pathway.
View Article and Find Full Text PDFMetab Brain Dis
January 2025
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus N, Denmark.
Background & Aims: Hepatic encephalopathy (HE), one of the most serious prognostic factors for mortality in alcohol-related cirrhosis (ALD cirrhosis), is not recorded in Danish healthcare registries. However, treatment of HE with lactulose, the universal first-line treatment, can be identified through data on filled prescriptions. This study aimed to investigate if lactulose can be used as a surrogate marker of HE.
View Article and Find Full Text PDFIndian J Pediatr
January 2025
Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, India.
Objectives: To evaluate the predictive ability of furosemide stress test (FST), serum and urine cystatin-C in identifying progressive acute kidney injury (AKI) and the need for kidney replacement therapy (KRT).
Methods: Children aged one month to 18 y admitted in the pediatric intensive care unit (PICU) with Kidney Diseases Improving Global Outcomes (KDIGO) stage-1/2 AKI were enrolled. FST and serum and urine cystatin-C levels were performed and analyzed.
Biogerontology
January 2025
Clinic for Heart Surgery (UMH), Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Straße 40, 06120, Halle (Saale), Germany.
If a shortened lifespan is evolutionarily advantageous, it becomes more likely that nature will strive to change it accordingly, affecting how we understand aging. Premature mortality because of aging would seem detrimental to the individual, but under what circumstances can it be of value? Based on a relative incremental increase in fitness, simulations were performed to reveal the benefit of death. This modification allows for continuous evolution in the model and establishes an optimal lifespan even under challenging conditions.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!